EcoR1 Capital’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,048,976
Closed -$28.9M 83
2021
Q2
$28.9M Buy
1,048,976
+452,076
+76% +$8.88M 1.08% 19
2021
Q1
$9.84M Buy
+596,900
New +$13.6M 0.44% 32

EcoR1 Capital's TBIO Position: Q3 2021 in Review

EcoR1 Capital sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,048,976 shares — an estimated $28.9M sold.

EcoR1 Capital first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $28.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • EcoR1 Capital reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • EcoR1 Capital sold 1,048,976 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $28.9M.
  • EcoR1 Capital first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • EcoR1 Capital's Translate Bio, Inc. Common Stock position peaked at $28.9M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on EcoR1 Capital's 13F filing for Q3 2021, filed 15 Nov 2021.